Pharmaceutical Technology Europe- February 2023

Pharmaceutical Technology Europe- February 2023

Issue link: https://www.e-digitaleditions.com/i/1492687

Contents of this Issue

Navigation

Page 12 of 32

Formulation challenges. Clinical supply hurdles. Limited manufacturing capability or capacity. Market fluctuations and demand surges. Lifecycle management. Risk mitigation. Patent expiry concerns. At BioPharma Solutions, a business unit of Baxter, we know the high-stakes challenges you face in today's complex parenteral marketplace — and how the work we do is vital to the patients you serve. That's why we work closely with you at every step to help you achieve your molecule's full potential and your commercialization objectives — building on over 90 years of innovation, expertise and specialization in parenterals. Learn more about us at biopharmasolutions.baxter.com Baxter is a registered trademark of Baxter International Inc. 920810-03 2023 BECAUSE WHEN IT'S ON THE LINE . . . EXPERIENCE MATTERS.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology Europe- February 2023 - Pharmaceutical Technology Europe- February 2023